Mark Ragosa

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals Corp., 100 Hayden Avenue, Lexington, MA
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Ragosa:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals International, plc CHIEF FINANCIAL OFFICER Class A Ordinary Share 26.5K $537K $20.28 Apr 7, 2025 Direct
Kiniksa Pharmaceuticals, Ltd. CHIEF FINANCIAL OFFICER Class A Common Share 19.3K $344K $17.88 Apr 26, 2024 Direct
Kiniksa Pharmaceuticals International, plc CHIEF FINANCIAL OFFICER Performance Share Unit 14.8K $264K $17.88 Apr 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF FINANCIAL OFFICER Share Option 29.5K Apr 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF FINANCIAL OFFICER Restricted Share Unit 2.69K Apr 7, 2025 Direct
Kiniksa Pharmaceuticals, Ltd. CHIEF FINANCIAL OFFICER Restricted Share Unit 990 Apr 26, 2024 Direct

Insider Reports Filed by Mark Ragosa

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals International, plc Apr 7, 2025 3 -$26.4K 4 Apr 9, 2025 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 1, 2025 9 -$35.2K 4 Apr 3, 2025 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Mar 20, 2025 3 -$162K 4 Mar 24, 2025 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Mar 16, 2025 9 -$216K 4 Mar 19, 2025 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Mar 12, 2025 3 -$374K 4 Mar 14, 2025 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Dec 6, 2024 6 -$359K 4 Dec 10, 2024 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Dec 3, 2024 9 -$160K 4 Dec 5, 2024 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Sep 1, 2024 9 -$86K 4 Sep 4, 2024 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Jul 23, 2024 3 -$332K 4 Jul 25, 2024 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 26, 2024 3 -$9.1K 4 Apr 30, 2024 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 4, 2024 6 -$14.2K 4 Apr 8, 2024 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2024 3 -$10.1K 4 Apr 3, 2024 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jan 3, 2024 3 -$134K 4 Jan 4, 2024 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 1, 2023 8 -$23.8K 4 Sep 6, 2023 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 26, 2023 3 -$3.24K 4 Apr 28, 2023 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 10, 2023 3 -$8.47K 4 Apr 11, 2023 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2023 2 $0 4 Apr 3, 2023 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 16, 2023 6 -$9.98K 4 Mar 20, 2023 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 1, 2022 5 -$6.26K 4 Sep 6, 2022 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 26, 2022 3 -$2.82K 4 Apr 28, 2022 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 7, 2022 2 $0 4 Apr 11, 2022 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 21, 2022 3 -$11.5K 4 Mar 23, 2022 CHIEF FINANCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 16, 2022 3 -$3.07K 4 Mar 18, 2022 Chief Financial Officer
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 2, 2021 2 $0 4 Sep 7, 2021 Chief Financial Officer